Invention Grant
- Patent Title: Teverelix-TFA composition
-
Application No.: US17254864Application Date: 2019-07-02
-
Publication No.: US11357818B2Publication Date: 2022-06-14
- Inventor: Guy Poland , Francois Boutignon
- Applicant: Antev Limited
- Applicant Address: GB London
- Assignee: Antev Limited
- Current Assignee: Antev Limited
- Current Assignee Address: GB London
- Agency: Fox Rothschild LLP
- Priority: EP18181945 20180705
- International Application: PCT/EP2019/067728 WO 20190702
- International Announcement: WO2020/007857 WO 20200109
- Main IPC: A61K38/09
- IPC: A61K38/09 ; A61K9/08 ; A61K47/12 ; A61P13/00 ; A61P35/00 ; A61P5/00
Abstract:
A teverelix-TFA composition having a molar ratio of teverelix to trifluoroacetate composition of at least 1:2.2 is provided. Such a molar ratio will prevent undesirable gel-formation and provide a homogenous suspension, whereby a unique bioavailablity of teverelix is obtained.
Public/Granted literature
- US20210236588A1 TEVERELIX -TFA COMPOSITION Public/Granted day:2021-08-05
Information query
IPC分类:
